Article ID Journal Published Year Pages File Type
5699932 Clinical Oncology 2006 6 Pages PDF
Abstract
Haemoglobin during radiotherapy and concurrent radio-chemotherapy is an independent prognostic factor in oesophageal cancer treatment. To improve outcome, it seems important to maintain the haemoglobin at 12-14 g/dl.
Keywords
Related Topics
Health Sciences Medicine and Dentistry Oncology
Preview
Prognostic Value of Haemoglobin Levels During Concurrent Radio-chemotherapy in the Treatment of Oesophageal Cancer
Authors
, , , ,